Data availability

Participant data are de-identified and available in the text, figures and tables. The statistical analysis plan is included in the clinical trial protocol, which is available in Supplementary Information . Requests for more information should be communicated to the corresponding author Y.S. Source data are provided with this paper.

Code availability

This work does not include any new code or software.

References

Yasunaga, S. et al. A mutation in OTOF , encoding otoferlin, a FER-1-like protein, causes DFNB9, a nonsyndromic form of deafness. Nat. Genet. 21 , 363–369 (1999).

Article CAS PubMed Google Scholar

Lv, J. et al. AAV1-hOTOF gene therapy for autosomal recessive deafness 9: a single-arm trial. Lancet 403 , 2317–2325 (2024).

Article CAS PubMed Google Scholar

Wang, H. et al. Bilateral gene therapy in children with autosomal recessive deafness 9: single-arm trial results. Nat. Med. 30 , 1898–1904 (2024).

Article CAS PubMed PubMed Central Google Scholar

Cheng, X. et al.…